INTRODUCTION 1
MicroRNAs (miRNAs) are implicated in the etiology of various diseases, including 2 cancer (1), and understanding their biologic characteristics has led to novel insights for cancer 3 diagnosis, treatment and prognosis (2) . MiRNAs are considered to be stable in healthy 4 individuals, but external factors including lifestyle can impact their expression. Several studies 5 have reported that physical activity (PA) can modulate miRNAs' expression (3) (4) (5) . The impact of 6 PA on reducing cancer risk and improving cancer progression has been well documented, but the 7 exact mechanisms underlying these relations are not yet completely understood (6, 7) . A better 8 understanding of altered expression and function of miRNAs in response to various forms of PA 9 could assist in clarifying the role of PA in cancer prevention and prognosis. 10 11
MiRNAs and cancer 12
MiRNAs are a class of small noncoding RNAs that regulate gene expression post-13 transcriptionally, either by mRNA cleavage, mRNA destabilization, or inhibition of translation 14 (8) . Since the first miRNA was discovered by Lee et. al. in 1993 , more than 2500 human miRNA 15 sequences have been identified (miRBase) (9) . This rapid expansion of discovery can be partially 16 explained by the broad importance of miRNAs in regular bodily functions. MiRNAs are 17 predicted to modulate more than 60% of protein-coding genes (10) and are involved in numerous 18 integral cellular processes, including development, proliferation, metabolism, and signal 19 transduction (11, 12) . Given their regulatory importance, it is not surprising that miRNAs are 20 widely implicated in carcinogenesis and progression. The mechanistic role of miRNAs in cancer 21 was first discussed by Johnson et. al. in 2005 (13) and the number of studies has been rapidly 22 expanding ever since. In both solid and hematological tumors, numerous miRNAs have been 23 found to be altered, and their expression are associated with the severity and stage at diagnosis 24 7 progression at various cancer sites are not fully understood and additional pathways are likely. 1
Since miRNAs are now well recognized for playing important roles in carcinogenesis and cancer 2 outcomes, they could be involved in the PA-related benefits towards cancer. 3
The impact of PA on miRNAs has been investigated by several research groups, but 4 mainly in the context of physical performance, muscle pathogenesis and muscular dysfunction 5 related to aging, as well as in muscle disorders associated with diabetes, cancer and inflammation 6 (3) . The majority of the miRNAs shown to be altered by either acute or chronic exercise in these 7 studies are muscle-specific miRNAs, also called myomiRs. MiRNAs are differentially expressed 8 within various organs, and if a miRNA is expressed more than 20-fold in a specific tissue 9 compared with the mean of its expression in other tissues, it is thus considered as a tissue-specific 10 miRNA (34) . The expression of a variety of miRNAs, and particulary myomiRs, is modulated by 11 PA within muscle tissues (4, 35) as well as in plasma (5) . Zacharewicz et. al. (4) have published a 12 detailed review on miRNA expression within muscles in response to PA. Here we restrict our 13 review to miRNA expression in blood following acute or chronic PA. 14 C-miRNAs are currently being extensively studied due to several advantages from a 15 clinical and etiological perspective including a remarkable stability in the circulation, resistance 16
to RNase activity (36), and preservation through multiple freeze-thaw cycles (37) . Consequently, 17 c-miRNAs can be easily evaluated by standard and relatively inexpensive qRT-PCR techniques, 18 even in low concentrations (38) , and their measurement is a non-invasive procedure (39) . This is 19
in stark contrast to the analysis of miRNA expression within specific tissues, which require 20 biopsies. Based on these differences, c-miRNAs measured from stored blood samples will prove 21 advantageous in the conduct of large epidemiological studies of PA-related cancer etiology. For 22 these reasons, in this review we focused on the role of c-miRNAs as an underlying mechanism 23 . Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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3
The majority of c-miRNAs are derived from leukocytes and endothelial cells (40) but they 4 can also originate from organs exposed to high blood flow (3) . When exercising, the blood flow 5 is significantly elevated, with up to a 80-fold blood flow increase in times of high physical output 6 (41, 42) , leading to expression changes in miRNAs originating from various organs (43) (44) (45) , and 7 in particular from skeletal muscles. The release of miRNAs in the blood circulation can originate 8 from destroyed tissues (46, 47) , especially if the exercise load is great (48) . However, increases in 9 the expression of c-miRNAs have also been reported in the absence of cell damage markers in 10 plasma (49) . MiRNAs can, in fact, be exported by active transport systems, either encapsulated in 11 extracellular vesicles (such as exosomes) (46, 50, 51) , or associated with protein or lipid-based 12 complexes (e.g., Argonaute2 (AGO2), high density lipoproteins (HDL) and low density 13 lipoproteins (LDL)) (36, [52] [53] [54] . Importantly, increasing evidence shows that miRNAs, through 14 their circulating form, can be transported from donor cells to recipient cells, where they exert 15 their functions (18, 54) . C-miRNAs are thus being recognized as important components in 16 intercellular communication (53, 55, 56) , and have notably been demonstrated to play key roles in 17 crucial cellular processes, such as apoptosis, proliferation, metastasis, and immunity (57, 56 
MATERIALS AND METHODS 1
We conducted a literature search up to March of 2016 in PubMed using the following 2 search strategy: « miRNAs AND exercise » or « miRNAs AND physical activity » or 3 « microRNAs AND exercise » or « microRNAs AND physical activity ». Only studies conducted 4 in humans containing data measuring circulating miRNAs were included. We did not employ a 5 minimum sample size threshhold and studies with small numbers of participants were also 6 included, as the total number of studies meeting our inclusion criteria was relatively small. 7
Studies examining populations with disease were excluded, and all studies included in the review 8 presented measurements among healthy subjects as underlying diseases may impact c-miRNAs. 9
To our knowledge, there are no data on the effect of PA on c-miRNA expression in cancer 10 patients. One study has investigated the impact of PA on miRNA expression within tumor tissue 11
based on an animal model, and is included in the discussion section. We also analyzed reference 12 lists of the identified studies for additional relevant articles. The title and abstract were examined, 13
and full text was obtained if the paper seemed eligible. No period or language restrictions were 14 applied. We compiled the results from studies investigating c-miRNA expression in response to a 15 single bout of PA (acute PA) in either normally active individuals (Table 1) or trained subjects 16 (Table 2) as well as the impact of a training period and/or regular PA (chronic PA) on basal c-17 miRNA expression (Table 3) . 18 Tables 1 and 2 With regards to the type of exercise, we considered predominantly endurance exercises as 1 exercises involving the whole body and increasing oxidative capacity and aerobic endurance (e.g. 2 a marathon run), while resistance exercises were defined as exercises using machines, weights, or 3 even individuals' body weight to stimulate muscle hypertrophy and increase muscular strength or 4 power (e.g. leg press, squats, pull-ups). We highlight the distinctions between normally active 5 and "trained" participants, based on information provided by the studies. We considered the 6 subjects trained if: 1) the subjects underwent a specific training program described in the study; 7
2) a large bout of exercise such as a marathon run was included in the protocol as undergoing 8 such an effort implies previous training (even though not always specified in the reviewed 9 studies); 3) the authors stated that the participants were "trained individuals" and/or part of a 10 competitive program. We considered the subjects "untrained" or "normally active" if the 11 participants engaged in recreational activity < 4 hours per week and/or if specified in the study . 12 In total, we included 5 studies examining normally active individuals and 10 studies investigating 13 trained individuals, according to our criteria. 14 To facilitate comparisons across studies, we present the data for c-miRNAs that were 15 examined in multiple studies. We first synthesize and discuss the results obtained for c-miRNA 16 expression following acute PA, followed by a discussion and synthesis of results examining basal 17 miRNA expression in response to chronic PA. 18 PA has also been shown to modulate miRNA expression within peripheral blood 19 mononuclear cells (PBMCs). PBMCs are leukocytes with a round nucleus, and comprise 20
lymphocytes (T cells, B cells, and natural killer cells), monocytes, and dendritic cells (59). 21
Similar to c-miRNAs, PBMC miRNAs can easily be detected by standard RT-qPCR techniques, 22
but it remains controversial whether their expression is similar or not to whole blood miRNAs 23 (60, 61) . Thus, even though two different research groups found an impact of acute PA in 24 .
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
RESULTS 1
We have identified a total number of 16 studies in our review, which are displayed in 2 tables 1, 2 and 3. Among these studies, 14 investigated c-miRNA expression in response to a 3 single bout of exercise (66) (67) (68) 48, 69, 49, 65, (70) (71) (72) (73) (74) (75) (76) , and six (49, 66, 71, 75, 77, 78) Acute PA refers to a single isolated PA session. It is clear that a single bout of PA alters 8 expression of several c-miRNAs shortly after its completion ( Table 1 and (68) . These c-miRNAs then returned to baseline expression after periods of inactivity, which has 16 been reported to be relatively slow in some studies (66) (67) (68) 70, 72) . 
Muscle-or cardiac-specific miRNAs 20
In healthy individuals, muscle-or cardiac specific miR-1, miR-133, miR-206, miR-499, 21 miR-208 are expressed at low levels in the circulation, whereas miR-486 is generally found in 22
higher concentrations (79, 74) . In response to PA, several studies have shown an increase in the 23 circulating forms of miR-1, miR-133, miR-206, miR-208 and miR-499 immediately after the 24 . Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 15, 2017; DOI: 10.1158/1055-9965.EPI-16-0969 13 completion of various PA modalities (FITT) (48, 68, 70, 72, 73, 75, 76) , and a decrease in miR-486 1 (66) . It can be noted that specific exercise modalities appear to impact changes in miRNA levels. 2 Banzet et. al. found different c-miRNA expression patterns in normally active participants who 3 underwent a downhill walk versus others who completed an uphill walk (68) . Downhill walking 4
is considered an eccentric exercise as the muscles actively lengthen during this effort, whereas 5 uphill walking induces active shortening of the muscles and is thus considered a concentric 6 exercise. Interestingly, Banzet et. al. found significantly higher muscle/cardiac specific c-miRNA 7 expression for participants who walked downhill compared to subjects walking uphill (68) . Thus, 8 these data suggest that the type of muscle contraction involved in the exercises impacts c-miRNA 9 expression. Furthermore, data from various studies also suggests that muscle/cardiac c-miRNAs 10 can be differentially expressed depending on PA's intensity. For example, when looking at c-11 miR-133, Uhlemann et. al. showed that modifications in c-miR-133 expression in response to PA 12 were correlated with phosphocreatine kinase (CPK) activity, a marker for muscle damages: the 13 more damaging the exercise was, the most altered c-miR-133 expression was (48) . 14
Modulations in muscle/cardiac c-miRNA expression post-exercise appear to be 15
temporary, yet the exact delay before a return to baseline values is unclear. When examining 16 measures taken one day post-exercise, most studies showed that muscle and cardiac specific c-17 miRNAs had returned to their basal value. Others, however, reported a decrease in expression of 18 those c-miRNAs compared to immediately after exercise, but still significantly elevated 19 compared to baseline values. Focusing on c-miR-1 for example, four studies found similar 20 expression of this c-miRNA between pre-exercise and 24 hours post exercise (49, 68, 75, 76) , 21 while one other observed significantly higher expression compared to baseline value (but 22 attenuated from expression measured immediately after exercise) (70) . 23
Interestingly, high inter-individual variation in c-miR-499 expression has been reported in 24 response to an acute bout of endurance exercise in two different studies (68, 72) which suggests 1 that c-miR-499 is highly dependent on participants' characteristics, notably their training status. 2
MiR-499 is a cardiac-specific miRNA and studies have shown its circulating form may represent 3 a marker of myocardial injury (80) (81) (82) (83) (84) . Strenuous exercises such as marathon running can induce 4 transient myocardial injuries (85) (86) (87) (88) , this risk being higher in less trained individuals (87, 89) . 5
Therefore, the inter-individual variation observed in c-miR-499 expression following a marathon 6 run may reflect variation in training among participants, and/or cardiac muscle exhaustion. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
suggested that the resistance exercise session, which resulted in unaltered c-miR-126 expression, 1 did not cause such damages (48) . 2 C-miR-146a, a miRNA known for playing a role in inflammation and immunity (91,92) 3 has also been found to be altered by acute PA, however, the effects appear to be highly dependent 4 on the type of activity intervention. Two studies have reported an up-regulation of this c-miRNA 5 in response to a single bout of endurance exercise in trained individuals (49, 72) , but Nielsen et. the studies (49, 67, 71) . In response to a 60 min cycle ergometer exercise bout below anaerobic 17 threshold, c-miR-221 has been found to be down-regulated in normally active participants by 18 undergoing an exhaustive bout of exercise (49) , while the other one reported no change in its 1 expression between before and after a resistance exercise session (67) . The differences observed 2 between studies are likely attributable to differences in protocols, suggesting that alterations of c-3 miRNAs in response to acute PA are dependent on the dose and type of exercise (FIIT) as well as 4 participants' characteristics (e.g. age, gender, fitness level, health status, personal history, diet, 5 smoking habits, etc). 6 7
Impact of chronic physical activity on c-miRNA expression 8
Chronic PA is defined as regular PA done over an extended time period (a minimum of 9 several weeks). Interestingly, contrary to what is observed for c-miRNA expression following an 10 acute bout of PA (Table 1 and 2), there is a general trend for a down-regulation of c-miRNAs 11 expression in response to chronic PA (Table 3) . Among the six different studies investigating the 12 impact of chronic PA on resting expression of c-miRNAs we included in our review, four were 13 intervention trials (49, 66, 71, 75) and two were observational studies (77, 78) . The blood samples 14 analyzed in those research projects were taken at rest, at least 12 hours after the last training 15 session. 16
Muscle-or cardiac-specific miRNAs 17
Cardiac-or muscle specific c-miRNA expression changes in response to chronic PA are 18 hard to measure because of their low concentrations in humans at rest, consequently, there are 19 limited results thus far. For c-miR-1, one study reported no change between its resting expression 20 before and after a 10-week marathon training period in either trained or untrained inidividuals 21 (75) , whereas two other research groups found its expression too low to interpret its measurement 22 (66, 78) . A trend towards a decrease in c-miR-133 expression in response to a supervised training 23 on a cycle ergometer was found by Nielsen et. al. (71) , while other studies reported no changes 24 .
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Author Manuscript Published OnlineFirst on November 15, 2017; DOI: 10.1158/1055-9965.EPI-16-0969 (49, 75) or non-detectable amounts for the quantification of c-miR-133 (66, 78) . Several studies 1 measured the resting expression of c-miR-206 (66, 78) , c-miR-208 (66) and c-miR-499 (66,78) 2 before and after a training period, but their expressions were too low to be interpreted. Finally, 3
Aoi et. al. found that a four week cycling program down-regulates c-miR-486 basal expression 4 (66) . 5
Other circulating miRNAs 6
When evaluating c-let-7d expression, a miRNA that has a crucial role in cell comparisons between studies are challenging and efforts should be devoted towards standardized 10 protocols and procedures for miRNA collection, analysis and reporting. 11
The studies included in this review suggest that PA modulates c-miRNA expression in 12 healthy individuals. Several studies have also observed that PA can alter c-miRNA expression 13 within disease populations such as patients with chronic kidney diseases (69) and pre-diabetic 14 individuals (97). To our knowledge, however, no data exists regarding the impact of PA on 15 miRNA in cancer patients. PA also appears to be able to influence miRNA expression within 16 organs other than skeletal muscles (98, 99) . Taken together, these elements suggest that PA may 17 influence c-miRNA expression in cancer patients, perhaps via c-miRNA intercellular 18 communication. This hypothesized mechanism is illustrated in Figure 1 
Impact of miRNAs on cancer risk and development 24
. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. and gastric cancers (101, (103) (104) (105) (106) (107) (108) . MiR-133 has also been shown to be modified within muscle 6 tissues in response to acute and chronic PA. More specifically, acute bouts of exercise seem to 7 increase muscular miR-133 expression (109, 110) , while training tends to decrease expression 8 (109, 26) . These data suggest that miR-133 can translocate from muscle tissue to blood vessels, 9
and that this miRNA can impact cancer progression as depicted in Figure 1 . Several studies 10 suggest that miR-133 targets several oncogenes, such as the epidermal growth factor receptor 11 (EGFR) (101) and the insulin-like growth factor 1 receptor (IGF1R) (108, 111) . When activated, 12 those oncogenes stimulate various pathways causing deregulation in several cell processes, 13 eventually leading to carcinogenesis. For example, activation of EGFR pathway leads to the 14 stimulation of intracellular signaling cascades such as the mitogen-activated protein 15 kinases/extracellular signal-regulated kinases (MAPK/ERK) pathway, which plays a role in cell 16 cycle progression, differentiation, proliferation, and apoptosis (112, 113) . When activated, the 17 EGFR pathways also stimulate the phosphoinositide 3-kinase -protein kinase B (PI3K/AKT) 18 cascade, known for its crucial role in regulation of apoptosis and protein synthesis (114, 115 ). An 19 increase in c-miR-133 by PA originating from muscle tissue, may therefore impact tumor cells 20 and regulate target oncogenes and associated pathways. 21
Similarly, let-7 is a tumor suppressor and pro-apoptotic miRNA (116) whose expression 22 is decreased in numerous cancers (117) , and reported to be modulated in plasma by exercise 23 (71, 77) . While no direct evidence was identified in humans, in an animal model, breast tumor-24 21 bearing mice who underwent five weeks of interval exercise training (treadmill running) had 1 increased let-7 expression within the tumor itself when compared to breast-tumor sedentary mice 2 (118) . Let-7 is known for inhibiting mRNA translation of well-known oncogenes, including the 3 RAS family (HRAS, KRAS, and NRAS) (13) and c-MYC (119) (120) . When activated, Ras 4 stimulates several signaling pathways, including MAPK cascade and PI3K/AKT (121), thereby 5 influencing many cellular functions. 6
We must note the complex and often paradoxical role of miRNAs, with several miRNAs 7 exerting stimulatory as well as inhibitory effects depending on cancer type or stage of the disease 8 (122) (123) (124) . MiR-221 and miR-222 for example have a dual role: they can either act as tumor 9 suppressors as oncogenes. On one hand, miR-221 and miR-222 have been found to relent cancer 10 progression in several cancer types, and their expression in the ciruclation have been found to be 11 altered by PA in several studies (49, 71, 72, 77, 78) . In gastrointestinal stromal tumors for example, 12 miR-221 and miR-222 are thought to have prophylactic effects by negatively regulating the stem 13 cell factor receptor KIT, and are found under-expressed in tumors when compared to healthy 14 tissues (125) (126) (127) . KIT is a receptor tyrosine-kinase (RTK), and its activation leads to the 15 stimulation of several intracellular signaling pathways, including the signal transducer and 16 activator of transcription 3 (STAT3), PI3K, phospholipase C (PLC), and the MAPK cascade (128-17 130) . KIT promotes cell survival, proliferation and motility (131) , and its inhibition by miR-221 18 and miR-222 therefore contributes to carcinogenesis suppression. Modulation of those miRNAs 19 by PA could thereby inhibit KIT activation, consequently lowering the risk of developing cancer. 20
On the other hand, miR-222 and miR-221 have been shown to act as oncomiRs in other 21 cancer types. In lung and liver cancer for example, these miRNAs have been shown to inhibit the 22 action of the phosphatase and tensin homolog (PTEN), known to inhibit MAPK/ERK pathway, 23 and the tissue inhibitor of metalloproteinases-3 (TIMP3), thereby enhancing cell proliferation and 24
. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on November 15, 2017; DOI: 10.1158/1055-9965.EPI-16-0969 22 migration through PI3K/AKT pathway (132) . The dual role played by miR-222 and miR-221 1 suggest that clarifying the influence of exercise modalities (endurance vs resistance, short vs long 2 duration, regular vs irregular training, etc.), tissue and/or cancer site of interest will be extremely 3 important in subsequent research. 4
Impact of miRNAs on cancer invasion and metastasis 5
PA also modulates c-miRNAs involved in cell proliferation, invasion and metastasis 6 ( Figure 2) . For example miR-21 is altered by resistance and endurance training (71, 72, 78) and is 7 also known for participating in tumor invasion. In fact, in vitro studies have shown that in several 8 cancer types, miR-21 knock-down mice displayed suppression of cell proliferation and tumor 9 growth (133), as well as reduced invasion and metastasis (133) (134) (135) . Furthermore miR-21 10 negatively regulates tumor suppressor programmed cell death 4 (PDCD4) (136) and downstream 11 signaling targets (137, 138) in colorectal cell lines. The results in this review (Tables 1, 2 
and 3) 12
suggest that acute exercise can transiently upregulate c-miR-21 expression (65, 93) , while chronic 13 exercise (which reflects physiological adaptations) can also lead to alterations in miR- 21 14 expression within circulation (71, 77) , however, the influence of chronic PA is less clear. By 15 lowering miR-21 expression within cancer cells, PA may restore PDCD4 and PTEN activation 16 and limit cancer proliferation. This is supported by literature that suggests PA is able to modulate 17 miR-21 within multiple tissues/fluids, for example muscle tissue in mice (139) as well as in 18 plasma in healthy human subjects (93, 65, 71, 77, 78) , as well as in tumors of breast tumor-bearing 19 mice (118) (Figure 1 ). 20
The up-regulation of c-miR-126 by acute PA (48, 72) might also represent a pathway 21 through which PA impacts cancer progression. In breast cancer, miR-126 regulates the tumor 22 microenvironment composition by directly inhibiting stromal cell-derived factor-1 alpha 23 (CXCL12) expression and indirectly suppressing chemokine ligand 2 (CCL2) expression in 24 .
Author Manuscript Published OnlineFirst on November 15, 2017; DOI: 10.1158/1055-9965.EPI-16-0969 23 cancer cells (140) . These two chemokines play a role in recruiting stromal cells to the primary 1 tumor microenvironment (141, 142) , thereby leading to cancer cell invasion and metastasis. 2 Therefore, the increase in c-miR-126 expression in response to acute PA followed by active 3 transport into tumor cells could lead to inhibition of CXCL12 and CCL2, consequently 4 suppressing cancer expansion by modifying the tumor microenvironment composition (48) . 5
Overall, PA-induced c-miRNA expression changes could have the potential to impact 6 tumorigenesis and cancer development. Importantly, several studies suggest that re-expression of 7 tumor-supressor miRNAs within tumor tissues can inhibit tumor growth, thereby representing a 8 promising therapeutic tool against cancer (18, (143) (144) (145) . For example, re-expression of let-7 9
within various tumor types have been proven to slow cancer growth (95, [146] [147] [148] and is thus 10 considered a promising tool against cancers under-expressing let-7 family members (146, 149) . 11
Additional research, particularly large intervention studies in populations of cancer patients are 12 needed to determine the exact impact of PA on miRNA expression and potential roles in cancer 13 therapy. 14
15

Limitations of the research to date 16
Investigating c-miRNAs in response to PA presents several challenges. First, to date, 17 there are few studies that have compared similar c-miRNAs using comparable methods to enable 18 direct comparisons across studies. Although some consistency has been observed for several c-19 miRNAs such as miR-133 (48, 70, 72, 73, 75, 76) , contradictory results have often been observed. 20
This inconsistency can largely be attributed to discrepancy in methods across studies, including: approach (71, 72) . Some studies also included a hemolysis control phase in the study design, since 4 it has been shown that hemolysis occurring during blood collection has substantial impact on the 5 miRNA content in plasma/serum (150) . This issue occurs because erythrocytes contain numerous 6 miRNAs that unavoidably will contaminate a plasma sample if the erythrocyte bursts during 7 sampling (151). 8
Another methodologic factor likely to impact the reliability of the results obtained from the 9 various studies reviewed here is the fact that miRNA concentrations vary between serum and 10 corresponding plasma samples (152) . Analyzing and comparing miRNA expression from serum 11 and plasma within or between studies should be done carefully. 12
To date, miRNA expression in response to PA has mainly been measured in the 13 circulation and in muscles, but it would also be interesting to study the changes in miRNA 14 expression in other tissues. More specifically, investigating miRNA expression after PA in target 15 tissues, and more specifically tumor tissues, would provide novel data of how PA can impact 16 cancer through miRNA modulation. Tissue-specific approaches would also aid in a better 17 understanding of the role of c-miRNAs in specific cancer sites that may result in the development 18 of targeted novel therapies. 19 20 
21
.
Author Manuscript Published OnlineFirst on November 15, 2017; DOI: 10.1158/1055-9965.EPI-16-0969
25
CONCLUSIONS AND FUTURE DIRECTIONS 1
PA represents a lifestyle behaviour that influences the expression of several c-miRNAs, 2 some of which have been associated with carcinogenesis and cancer progression. Our results 3 suggest that alteration of miRNAs within the circulation is dependent on the 4 type/modality/frequency of exercise as well as on the participants characteristics. Furthermore, 5 the evidence to date on c-miRNA expression in response to PA is limited by small sample sizes 6 without standardized measures of miRNA or physical activity. miRNAs appear to have a 7 meaningful impact on cancer risk and progression, however, the effect vary between cancer 8 types. Therefore, it appears essential to provide a better understanding of how various types of 9 PA in a specific population could impact c-miRNA expression: it could represent a useful tool for 10 healthcare practionners in establishing and monitoring PA programs for cancer patients. *Results of a systematic review of studies investigating the impact of acute PA on c-miRNA expression in healthy and "normal" activity levels humans subjects either immediately after acute exercise completion and/or several hours up to a couple days after.
Abbrevations: ex: exercise; wk: week; yrs: years.
. Legend: ‡ is placed after borderline significant miRNAs *Results of a literature review of intervention and observational studies investigating the impact of chronic PA on c-miRNA expression in humans.
Abbrevations: No: number; yrs: years.
. which impact pathways involved in cancer risk and progression have been shown to be altered by physical activity.
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